Propanc Biopharma, Inc.
Climate Impact & Sustainability Data (2019)
Reporting Period: 2019
Environmental Metrics
Climate Goals & Targets
Medium-term Goals:
- Complete Phase IIa study for PRP within the proposed budget (approximately three to four years).
Short-term Goals:
- Submit a clinical trial application in the fourth calendar quarter of 2019.
Environmental Challenges
- Ability to continue as a going concern absent new debt or equity financings.
- Material weaknesses in internal controls.
- Inability to repay substantial debt financing.
- Need for substantial additional funding.
- Limited public market for common stock.
- Lack of independent directors.
- Significant increased costs as a result of operating as a public company.
Mitigation Strategies
- Actively exploring various alternatives to reduce debt.
- Planning to take actions to correct material weaknesses, including establishing an audit committee and adding experienced accounting and financial personnel.
- Seeking additional funds through issuance of equity and/or debt securities.
- Implementing a Reverse Stock Split to meet OTCQB quotation requirements.
- Continuing to incur significant legal, accounting and other expenses associated with operating as a public company.